Inloggad som:
SIRPa CA059-001
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
SIRPa CA059-001
A phase 1, open-label, dose finding study of CC-95251 alone and in combination with antineoplastic agents in subjects with acute myeloid leukemia and myelodysplastic syndromes
A phase 1, open-label, dose finding study of CC-95251 alone and in combination with antineoplastic agents in subjects with acute myeloid leukemia and myelodysplastic syndromes
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2023-03-19)